On August 28, 2025, the Internal Revenue Service (IRS) issued Revenue Procedure 2025-28, providing procedural guidance for taxpayers on the treatment of research and experimental (R&E) expenditures[1] ...
The Internal Revenue Service headquarters in Washington, D.C. The Internal Revenue Service has provided guidance on how to deal with the restoration of full expensing of research and development costs ...
Though Merck’s 2024 R&D spending plummeted by almost $13 billion compared to 2023, the New Jersey pharma still came in $700 million ahead of its closest competitor, Johnson & Johnson. Merck's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results